Single Arm Romiplostim to Prevent CIT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Single Arm Romiplostim to Prevent CIT — Stella

Home/Ewings Sarcoma/

View on ClinicalTrials.gov

Recruiting

Back to Ewings Sarcoma trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

United States

Phoenix Children's, Phoenix, Arizona

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Key details

Phase

Very early testing

Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment target

~26 participants

Started

January 2024

Primary completion

January 2027

Age range

1 Year and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.